Véronique Lecault ^UDM

Véronique Lecault is the COO at AbCellera Biologics Inc., a biotech firm in Vancouver. With its focus on developing human antibodies, AbCellera is renowned for its contribution to the Pandemic Prevention Platform under DARPA's Biological Technologies Office. Leveraging the proprietary Trianni humanized mouse platform, the company innovates in antibody gene design, enhancing antibody diversity. Lecault's role is pivotal in overseeing these groundbreaking operational aspects.